Feed Preview

Fast Growing

Oxygen Tension in Liver Models

Donald A. Belcher et al

Oxygen tension is determined by the balance between net oxygen entering the system and the consumption of oxygen by cells, which can be affected by cell density and type. For instance, hepatocytes consume higher levels of oxygen compared to endothelial cells. Here is the latest research on oxygen tension in liver models.

Top 20 most recent papers

The chances of hepatic resection curing hepatocellular carcinoma

Journal of HepatologyNovember 29, 2019

Alessandro CucchettiPhilip James Johnson

Microscale Collagen and Fibroblast Interactions Enhance Primary Human Hepatocyte Functions in 3-Dimensional Models

bioRxivNovember 29, 2019

David A KuklaSalman R Khetani

High-Resolution 3D Fluorescent Imaging of Intact Tissues

bioRxivNovember 26, 2019

Danny El-NachefWilliam R MacLellan

A randomized controlled trial of an integrated alcohol reduction intervention in patients with hepatitis C infection

Hepatology : Official Journal of the American Association for the Study of Liver DiseasesDecember 5, 2019

Rae Jean Proeschold-BellAndrew J Muir

Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease

Journal of HepatologyNovember 21, 2019

Amine MajdiJérémie Gautheron

Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis

Journal of HepatologyNovember 27, 2019

Behzad HajarizadehJason Grebely

An Open Label, Dose Escalation Study To Assess The Safety And Efficacy Of IL-22 Agonist F-652 In Patients With Alcoholic Hepatitis

Hepatology : Official Journal of the American Association for the Study of Liver DiseasesNovember 27, 2019

Juan Pablo ArabVijay H Shah

Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma

Nature CommunicationsNovember 26, 2019

Shuang ZhangBenjamin G. Neel

Corrigendum to "Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis" [J Hepatol 71 (2019) 763-772

Journal of HepatologyNovember 25, 2019

Marc BonninSerge J Lebecque

Ultra-thin fluorocarbon foils optimise multiscale imaging of three-dimensional native and optically cleared specimens

Scientific ReportsNovember 21, 2019

Katharina HötteFrancesco Pampaloni

Reply: Alcohol and mortality in NAFLD: Is the cabernet causal or confounder?

Hepatology : Official Journal of the American Association for the Study of Liver DiseasesDecember 1, 2019

Fredrik AbergAntti M Jula

New insights from liver-humanized mice on cholesterol lipoprotein metabolism and LXR-agonist pharmacodynamics in humans

Hepatology : Official Journal of the American Association for the Study of Liver DiseasesNovember 30, 2019

Mirko E MinnitiPaolo Parini

Impact of Alcohol Use Disorder Treatment on Clinical Outcomes among Patients with Cirrhosis

Hepatology : Official Journal of the American Association for the Study of Liver DiseasesNovember 23, 2019

Shari S RogalKevin L Kraemer

Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer

Cell Stem CellNovember 19, 2019

Ye YaoGuoqiang Hua

Economic and Healthcare Burdens of Hepatitis Delta: A Study of Commercially Insured Adults in the United States

Hepatology : Official Journal of the American Association for the Study of Liver DiseasesDecember 5, 2019

Mohamed I ElsaidVinod K Rustgi

Growth differentiation factor 11 attenuates liver fibrosis via expansion of liver progenitor cells

GutNovember 25, 2019

Zhen DaiAmar Deep Sharma

Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming of impaired regeneration pathways in mice

Journal of HepatologyNovember 28, 2019

Xiao-gang XiangBin Gao

The Phosphatidylethanolamine Biosynthesis Pathway Provides a New Target for Cancer Chemotherapy

Journal of HepatologyNovember 21, 2019

Yuan GuanGary Peltz

De Novo-Designed Near-Infrared Nanoaggregates for Super-Resolution Monitoring of Lysosomes in Cells, in Whole Organoids and In Vivo

ACS NanoDecember 4, 2019

Hongbao FangJiaJie Diao

MVP promotes hepatocellular carcinoma via targeting IRF2 and decreasing p53 activity

Hepatology : Official Journal of the American Association for the Study of Liver DiseasesNovember 23, 2019

Haisheng YuShi Liu

See more papers from this feed

Related Feeds

Adult Kidney Organoids at Single Cell Resolution

Single-cell RNA sequencing of the adult human kidney transcriptome can provide molecular information about cell-specific responses to environmental variables and disease states. This information can provide a dataset to benchmark human kidney organoids. Discover the latest research on adult kidney organoids at single cell resolution here.

Artificial Cell Models

This feed focuses on biomimetrics, synthetic biology and bio- and tissue-engineering approaches used for modeling human diseases.

Artificial Heart & Ventricular Assist Devices

Total artificial hearts (TAH) and ventricular assist devices (VADs) provide cardiac support for patients with end-stage heart disease and have significantly improved the survival of these patients. Discover the latest research on Artificial Heart and Ventricular Assist Devices here.

Biomaterial Engineering

Advances in biomaterial engineering have permitted the development of sophisticated drug-releasing materials with a biomimetic 3D support that allow a better control of the microenvironment of transplanted cells. Here is the latest research.

Brain Organoids in Disease Modeling

Brain organoids are used to represent an in vitro model of the human brain. These brain organoids are derived from three-dimensional human pluripotent stem cells and can be used to help study brain biology, early brain development and different brain diseases. Discover the latest research on brain organoids in disease modeling here.

CFTR Mutant Structural Therapy

Over 1700 different mutations in the CFTR genes have been shown to cause cystic fibrosis. Here is the latest research on structural therapy for CFTR mutants.

CRISPR Genome Editing & Therapy

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of this system for gene editing and therapy in human diseases.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Cardiac Organoids

Cardiac organoids are 3D organ-like structures that can be derived from patients with cardiovascular diseases and are important disease models for drug discovery. Discover the latest research on Cardiac Organoids here.

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.

Contact Help Terms Privacy Cookies